We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
-$76.2M
(-0.7%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
28.27%
Holding
568
New
2
Increased
152
Reduced
375
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$113M |
| 2 |
Amazon
AMZN
|
+$16.9M |
| 3 |
Snowflake
SNOW
|
+$15.1M |
| 4 |
Palantir
PLTR
|
+$7.78M |
| 5 |
Analog Devices
ADI
|
+$7.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.8M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$22.7M |
| 3 |
Microsoft
MSFT
|
+$16.2M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.5M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Financials | 14.45% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 11.84% |
| 5 | Communication Services | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Live Nation Entertainment
LYV
$42B
| $4.93M | 0.05% |
54,085
-5,994
| -10% | -$505K |
|
402
Bio-Rad Laboratories Class A
BIO
$9.32B
| $4.92M | 0.05% |
6,600
-300
| -4% | -$225K |
|
403
Apollo Global Management
APO
$73.5B
| $4.92M | 0.05% |
79,800
-2,000
| -2% | -$120K |
|
404
Nordson
NDSN
$17.3B
| $4.91M | 0.05% |
20,630
-1,970
| -9% | -$455K |
|
405
Pool Corp
POOL
$7.5B
| $4.87M | 0.04% |
11,200
-100
| -0.9% | -$47.4K |
|
406
Dynatrace
DT
$14.1B
| $4.85M | 0.04% |
68,300
-5,900
| -8% | -$387K |
|
|
CTXS
407
DELISTED
Citrix Systems Inc
CTXS
| $4.85M | 0.04% |
45,134
+5,800
| +15% | +$626K |
|
408
Jazz Pharmaceuticals
JAZZ
$16.7B
| $4.81M | 0.04% |
36,947
+3,800
| +11% | +$574K |
|
409
SEI Investments
SEIC
$12.5B
| $4.8M | 0.04% |
81,036
+5,153
| +7% | +$314K |
|
410
Novavax
NVAX
$1.31B
| $4.79M | 0.04% |
23,100
-800
| -3% | -$176K |
|
411
Cognex
CGNX
$11.3B
| $4.79M | 0.04% |
59,663
-7,000
| -11% | -$602K |
|
412
Vail Resorts
MTN
$5.32B
| $4.77M | 0.04% |
14,281
-500
| -3% | -$154K |
|
413
Voya Financial
VOYA
$9.25B
| $4.73M | 0.04% |
77,120
+5,400
| +8% | +$344K |
|
414
Lyft
LYFT
$6.56B
| $4.71M | 0.04% |
87,973
-3,527
| -4% | -$187K |
|
415
Masco
MAS
$15.3B
| $4.69M | 0.04% |
84,415
+3,100
| +4% | +$184K |
|
416
Conagra Brands
CAG
$7.23B
| $4.68M | 0.04% |
138,106
-11,000
| -7% | -$372K |
|
417
Elanco Animal Health
ELAN
$11.1B
| $4.67M | 0.04% |
146,589
-3,500
| -2% | -$117K |
|
418
Zillow
Z
$7.51B
| $4.67M | 0.04% |
53,041
-1,500
| -3% | -$152K |
|
419
Sensata Technologies
ST
$6.77B
| $4.67M | 0.04% |
85,306
+9,200
| +12% | +$529K |
|
420
Steel Dynamics
STLD
$37.5B
| $4.64M | 0.04% |
79,363
-13,100
| -14% | -$837K |
|
421
Cardinal Health
CAH
$55.8B
| $4.63M | 0.04% |
93,520
-3,500
| -4% | -$190K |
|
422
SolarEdge
SEDG
$1.96B
| $4.62M | 0.04% |
17,400
-1,400
| -7% | -$381K |
|
423
ON Semiconductor
ON
$19.3B
| $4.61M | 0.04% |
100,803
-6,800
| -6% | -$291K |
|
424
Qorvo
QRVO
$8.67B
| $4.6M | 0.04% |
27,517
-2,511
| -8% | -$467K |
|
425
Seagate
STX
$186B
| $4.59M | 0.04% |
55,600
-7,200
| -11% | -$626K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Fjarde Ap-fonden held 568 positions worth $10.8B, down 0.7% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.9%. Fjarde Ap-fonden opened 2 new positions and exited 9, leaving the 568-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Fjarde Ap-fonden's largest Q3 2021 buy was DoorDash: 26,300 shares worth $5.42M.
- Fjarde Ap-fonden added most to iShares MSCI USA Value Factor ETF in Q3 2021, an estimated $113M increase.
- Fjarde Ap-fonden's biggest Q3 2021 reduction was Apple, cutting an estimated $22.8M.
- Fjarde Ap-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $12.5M.
- Fjarde Ap-fonden's ten largest holdings make up 28% of its $10.8B portfolio in Q3 2021.
- Fjarde Ap-fonden opened 2 new positions and closed 9 in Q3 2021.
- Fjarde Ap-fonden's portfolio value fell 0.7% quarter-over-quarter to $10.8B.
Based on Fjarde Ap-fonden's 13F filing for Q3 2021, filed 15 Nov 2021.